Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON)

N. Thielen; B. van der Holt; J.J. Cornelissen; G.E.G. Verhoef; T. Gussinklo; B.J. Biemond; S.M.G. Daenen; W. Deenik; R.V. Kooy; E. Petersen; W.M. Smit; P.J.M. Valk; G.J. Ossenkoppele; J.J.W.M. Janssen

doi:10.1016/j.ejca.2013.06.018

Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON)

N. Thielen, B. van der Holt, J.J. Cornelissen, G.E.G. Verhoef, T. Gussinklo, B.J. Biemond, S.M.G. Daenen, W. Deenik, R.V. Kooy, E. Petersen, W.M. Smit, P.J.M. Valk, G.J. Ossenkoppele, J.J.W.M. Janssen

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	3242-3246
Journal	European Journal of Cancer
Volume	49
Issue number	15
DOIs	https://doi.org/10.1016/j.ejca.2013.06.018
Publication status	Published - 2013

Access to Document

10.1016/j.ejca.2013.06.018

Cite this

Thielen, N., van der Holt, B., Cornelissen, J. J., Verhoef, G. E. G., Gussinklo, T., Biemond, B. J., Daenen, S. M. G., Deenik, W., Kooy, R. V., Petersen, E., Smit, W. M., Valk, P. J. M., Ossenkoppele, G. J., & Janssen, J. J. W. M. (2013). Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON). European Journal of Cancer, 49(15), 3242-3246. https://doi.org/10.1016/j.ejca.2013.06.018

Thielen, N. ; van der Holt, B. ; Cornelissen, J.J. ; Verhoef, G.E.G. ; Gussinklo, T. ; Biemond, B.J. ; Daenen, S.M.G. ; Deenik, W. ; Kooy, R.V. ; Petersen, E. ; Smit, W.M. ; Valk, P.J.M. ; Ossenkoppele, G.J. ; Janssen, J.J.W.M. / Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON). In: European Journal of Cancer. 2013 ; Vol. 49, No. 15. pp. 3242-3246.

@article{c660818beeee4e9b84b2440a0a668c5c,

title = "Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON)",

author = "N. Thielen and {van der Holt}, B. and J.J. Cornelissen and G.E.G. Verhoef and T. Gussinklo and B.J. Biemond and S.M.G. Daenen and W. Deenik and R.V. Kooy and E. Petersen and W.M. Smit and P.J.M. Valk and G.J. Ossenkoppele and J.J.W.M. Janssen",

year = "2013",

doi = "10.1016/j.ejca.2013.06.018",

language = "Undefined/Unknown",

volume = "49",

pages = "3242--3246",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Pergamon",

number = "15",

}

Thielen, N, van der Holt, B, Cornelissen, JJ, Verhoef, GEG, Gussinklo, T, Biemond, BJ, Daenen, SMG, Deenik, W, Kooy, RV, Petersen, E, Smit, WM, Valk, PJM, Ossenkoppele, GJ & Janssen, JJWM 2013, 'Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON)', European Journal of Cancer, vol. 49, no. 15, pp. 3242-3246. https://doi.org/10.1016/j.ejca.2013.06.018

Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON). / Thielen, N.; van der Holt, B.; Cornelissen, J.J.; Verhoef, G.E.G.; Gussinklo, T.; Biemond, B.J.; Daenen, S.M.G.; Deenik, W.; Kooy, R.V.; Petersen, E.; Smit, W.M.; Valk, P.J.M.; Ossenkoppele, G.J.; Janssen, J.J.W.M.

In: European Journal of Cancer, Vol. 49, No. 15, 2013, p. 3242-3246.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON)

AU - Thielen, N.

AU - van der Holt, B.

AU - Cornelissen, J.J.

AU - Verhoef, G.E.G.

AU - Gussinklo, T.

AU - Biemond, B.J.

AU - Daenen, S.M.G.

AU - Deenik, W.

AU - Kooy, R.V.

AU - Petersen, E.

AU - Smit, W.M.

AU - Valk, P.J.M.

AU - Ossenkoppele, G.J.

AU - Janssen, J.J.W.M.

PY - 2013

Y1 - 2013

U2 - 10.1016/j.ejca.2013.06.018

DO - 10.1016/j.ejca.2013.06.018

M3 - Article

VL - 49

SP - 3242

EP - 3246

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 15

ER -

Thielen N, van der Holt B, Cornelissen JJ, Verhoef GEG, Gussinklo T, Biemond BJ et al. Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON). European Journal of Cancer. 2013;49(15):3242-3246. https://doi.org/10.1016/j.ejca.2013.06.018